Fingerprint
Dive into the research topics of 'A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically